评估移植后淋巴细胞形成的预测因素
Oleksandr Boiko1, Ignacio Garcia-Alonso2, Adela Navarro1
1Urology Department, University Hospital of Cruces Cruces Plaza, Bizkaia, Spain.
Progress in transplantation (Aliso Viejo, Calif.)
|October 13, 2024
概括
患有慢性管介质炎的移植患者面临更高的淋巴细胞发病风险,这是一个常见的移植后并发症. 了解末期病病因有助于预测淋巴细胞形成.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 移植手术 移植手术
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
背景情况:
- 淋巴细胞是移植后经常出现的并发症.
- 风险因素包括手术技术,BMI和免疫治疗.
- 确定特定的风险因素对于患者管理至关重要.
研究的目的:
- 为了研究移植患者的淋巴细胞风险因素.
- 具体评估末期病 (ESKD) 病因在淋巴细胞发育中的作用.
主要方法:
- 对291名移植接受者的回顾性分析 (2020年3月至2022年12月).
- 收集了关于患者人口统计,病史,移植变量和结果的数据.
- 患者根据淋巴细胞发育 (症状与无症状) 进行了分类.
主要成果:
- 19.6%的接受者患有淋巴结核;5.1%有症状.
- 较低的BMI (<24.9 kg/m2) 与淋巴细胞风险降低相关 (OR 0.538,P=0.046).
- 慢性管间炎显著增加了淋巴细胞风险 (46.2%,OR 3.815,P=0.024),而焦点细分型结核硬化没有风险 (0.0%,OR 0.123,P=0.048).
结论:
- 末期病病因是术后淋巴细胞发育的重要预测因素.
- 需要进一步的前性研究来证实这些发现,并探索ESKD的作用.
- 根据ESKD类型量身定制风险评估可以改善淋巴结核预防策略.
相关概念视频
01:16Kidney Transplant III: Nursing Management
3
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
3
01:26Kidney Transplant II: Surgical Procedure
2
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
2
01:28Kidney Transplant I: Introduction
2
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
2